Protected: The Microbiome Biotech Landscape: An Analysis of the Pharmaceutical Pipeline

Microbiome science is rapidly expanding to pharmaceuticals and diagnostics. Here, Sandwalk BioVentures present their analysis of the market of these emerging pharmabiotics companies.

This content is password protected. To view it please enter your password below:

Luis Gosálbez
Managing Director at

Sandwalk BioVentures is a specialty strategy, innovation, regulatory and management consulting firm focused on microbiome technologies servicing companies in the food and pharma sectors, as well as financial and strategic investors exploring to enter this field. The company has created the Microbiome Drug Database™, an online repository containing the most extensive and thorough analysis of biotechnology companies developing pharmaceuticals from or through the microbiome.